== Research Topics==
In the field of rheumatic diseases, particularly rheumatoid arthritis * Systemic Lupus Erythematosus [RASLE] and systemic lupus erythematosus Rheumatoid Arthritis [SLERA],* Clinical Epidemiology (including clinimetrics, clinical trials and innovative treatment development, clinical and pharmaco-economics, and outcomes research)
* Genetic Epidemiology including drug discovery and repurposing
* Precision Medicine Prof Bae’s research has the overall theme of understanding clinical, environmental & genetic factors associated with rheumatic diseases (RA and SLE) and their individual prognosis and drug response prediction for the precision medicine. For this purpose, as one of the most prominent clinician and researchers in Asia in this field, he has established large Korean RA & SLE cohorts, solved clinically important questions, and identified clinical predictors and dozens of common genetic variants and epidemiologic factors conferring risk of the diseases using the advanced methodology like GWAS, NGS, immunochip and HLA imputation for multiple ancestral populations. With these studies, he has also discovered novel biologic insights and therapeutic targets which implicate a potential guiding role of human RA/SLE genetics data in drug discovery and repurposing. He has successfully administered and participated in many multinational and multicenter projects as a principal investigator and co-investigator and he is always well aware of the factors needed for a successful research project which he will carry out.
Prof Bae’s research has the overall theme of understanding clinical, environmental & genetic factors associated with SLE and RA and their individual prognosis and drug response prediction for the precision medicine. For this purpose, as one of the most prominent clinician and researchers in Asia in this field, he has established largest Korean SLE & RA cohorts, solved clinically important questions, and identified clinical predictors and dozens of common genetic variants and epidemiologic factors conferring risk of the diseases using the advanced methodology like GWAS, NGS, immunochip, and HLA imputation for multiple ancestral populations. With these studies, he has also discovered novel biologic insights and therapeutic targets which implicate a potential guiding role of human SLE/RA genetics data in drug discovery and repurposing. In addition, he has already started to go beyond genetics and conduct thorough integrated analyses with epigenetics, transcriptomics, proteomics and more. He has successfully administered and participated in many multinational and multicenter projects as a principal investigator and co-investigator and he is always well aware of the factors needed for a successful research project which he will carry out.
== Papers==